Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

Summary

The primary objective of this study is to assess the efficacy of cannabidiol oral solution on hyperphagia-related behavior in patients with Prader-Willi Syndrome (PWS). The secondary objectives of this study are to assess the efficacy, safety and tolerability, impact on quality of life, and impact on physical activity of cannabidiol oral solution in patients with PWS.

Timeline

Start

2018-05-09

Primary completion

2019-07-17

Completion

2019-07-31

Outcome

Outcome not reported

Stopped: “Insys Therapeutics filed Chapter 11 and terminated all studies.”

Drugs

Indications